In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug.
Vetenskapsnyheter
A new study found that the number one environmental factor influencing brain structure and function is the socioeconomic status of a child's family.
Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.
Major Medicare Advantage plans almost always reversed their denials on appeal, raising big questions about barriers to care.
Seniors' drug costs rise sharply, Enliven's leukemia drugs, and more biotech news from The Readout
More employers are planning to drop coverage of GLP-1 drugs for weight loss next year as increasing numbers of people take the medications
A targeted drug from Enliven Therapeutics induced molecular responses in nearly half of patients with advanced leukemia, new data show.
Proving out a "synthetic lethality" approach can help treat cancer will take a lot more work. It also might trigger some creative deal-making.
Soda and liver cancer, scientists conflicted on a new NIH proposal, and more health news from Morning Rounds
Without easy access to leaders within a field or top-of-the-line lab equipment, principal investigators outside top universities often struggle to compete for grants from the NIH.
Long Covid hasn’t disappeared. It’s just gone underground, writes Steven Phillips.
In 2025, Elizabeth Selvin and her colleagues published in Nature Medicine for free. In 2026, it cost them $12,850, she writes.
Federal investigation finds Medicare Advantage insurers block rehab care for older adults, only to reverse denials on appeal.
The American Diabetes Association CEO apologizes to five members kicked out of annual convention for distributing protest literature, launches review of what went awry.
In this edition of AI Prognosis: Quirky medical data tripping up sepsis algorithms, AI scribes for patients, and some AI biotech news.
The American College of Obstetricians and Gynecologists has released a recommended vaccine schedule during pregnancy, one that diverges from CDC guidance.
Drug pricing in Europe, AI deals for VC firms, and more biotech news from The Readout
A new analysis found the average drug shortage in 2025 had lasted 5.3 years, exceeding the 4.3 years seen in 2024
A new era of American sunscreen, NIAID taps new acting director, and more health news from Morning Rounds
“Legal protection for abortion does not mean equitable access for minors,” a pediatrics resident writes.
In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and patients — and testing the influence of the U.S.
“I know what I’m getting into”: Dawn Zuidgeest-Craft on starting medical residency at almost 73.
Federal actions and proposals have reignited debate over methadone and buprenorphine, worrying addiction experts and patient groups.
STAT+: The shortage of many medicines in the U.S. remains a ‘systemic’ problem, a new analysis finds
The number of prescription drug shortages in the U.S. fell by 23% last year, but a new analysis found other troubling signs about medicines in short supply.
Plus a buried alcohol study gets published, and a Biosecure update.